[go: up one dir, main page]

Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6

J Immunol. 1994 Jul 1;153(1):153-64.

Abstract

Transcriptional activation of the IL-8 gene by several inflammatory mediators, including the cytokines IL-1 and TNF-alpha, is mediated through sequences located between nucleotide -94 and -71 of the IL-8 promoter. Because adjacent binding sites for the inducible transcription factors NF-kappa B and NF-IL-6 are located within this region, we examined the functional interaction of these two transcription factor families in IL-8 gene regulation. Maximal transcriptional activation by PMA in Jurkat T lymphocytes was shown to require intact binding sites for both NF-kappa B and NF-IL-6. Electrophoretic mobility shift analysis indicates that NF-IL-6, as well as other related members of this family, bind specifically to the NF-IL-6 site in the IL-8 promoter. In addition, NF-kappa B p65 (RelA), but not NF-kappa B p50 (NFKB1), binds specifically to the NF-kappa B site. When incubated together, RelA and NF-IL-6/C/EBP form a ternary complex with this region of the IL-8 promoter; this binding is dependent on intact binding sites for both NF-IL-6 and RelA. Transient cotransfection analyses indicate that the cooperative association of NF-IL-6 and RelA with the IL-8 promoter results in synergistic transcriptional activation. Mutational analyses of RelA demonstrate that the C-terminal transactivation domain and the DNA binding domain are required for synergistic activation with NF-IL-6. In addition, overexpression of the NF-kappa B inhibitor molecule, I kappa B, abolished the RelA- and RelA/NF-IL-6-dependent synergistic activation. These data demonstrate that RelA and members of the C/EBP/NF-IL-6 family can functionally cooperate in transcriptional activation of the IL-8 gene and suggest a common mechanism for inducible regulation of cytokine gene expression.

MeSH terms

  • Base Sequence
  • Binding Sites
  • CCAAT-Enhancer-Binding Proteins
  • DNA-Binding Proteins / administration & dosage*
  • DNA-Binding Proteins / metabolism
  • DNA-Binding Proteins / pharmacology
  • Drug Synergism
  • Gene Expression Regulation*
  • Humans
  • In Vitro Techniques
  • Interleukin-8 / genetics*
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • NF-kappa B / administration & dosage*
  • Nuclear Proteins / administration & dosage*
  • Nuclear Proteins / pharmacology
  • Oligodeoxyribonucleotides / chemistry
  • Promoter Regions, Genetic*
  • RNA, Messenger / genetics
  • Recombinant Proteins
  • Structure-Activity Relationship
  • Transcription, Genetic
  • Tumor Cells, Cultured

Substances

  • CCAAT-Enhancer-Binding Proteins
  • DNA-Binding Proteins
  • Interleukin-8
  • NF-kappa B
  • Nuclear Proteins
  • Oligodeoxyribonucleotides
  • RNA, Messenger
  • Recombinant Proteins